Disclosed is an antibody, or an antigen-binding fragment thereof, having three heavy chain complementary determining regions (CDRs) and three light chain CDRs, wherein each heavy chain CDR comprises the amino acid sequence of the corresponding heavy chain CDR of mAb TNV148 as described in Figure 4 and each light chain CDR of mAb TNV 148 as described in Figure 5.